Monoclonal antibodies as carriers of toxins.
Uhr
J W
JW
Department of Microbiology, University of Texas, Southwestern Medical Center, Dallas 75235.
Fulton
R J
RJ
Till
M A
MA
May
R D
RD
Vitetta
E S
ES
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D003131:Combined Modality Therapy; D007072:Immunoglobulin D / Q000276:immunology / Q000627:therapeutic use; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D000922:Immunotoxins / Q000302:isolation & purification / Q000378:metabolism / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D008099:Liver / Q000378:metabolism; D051379:Mice; D011994:Recombinant Proteins / Q000627:therapeutic use; D012276:Ricin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013154:Spleen / Q000378:metabolism; D013156:Splenectomy
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007072:Immunoglobulin D; D007140:Immunoglobulin Fab Fragments; D000922:Immunotoxins; D011994:Recombinant Proteins; C039951:anti-IgD; D012276:Ricin